marijuana stocks news

OXIS International, Inc. (OXIS)

 

 

Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue 33   3   25   –  
Cost of Revenue 35 5 17
Gross Profit (2) (2) 8   –  
Operating Expenses
Research Development
Selling General and Administrative 1,640 547 112 101
Non Recurring
Others
Total Operating Expenses
Operating Income or Loss (1,642) (549) (104) (101)
Income from Continuing Operations
Total Other Income/Expenses Net (15,495) (407) 11 (72)
Earnings Before Interest And Taxes (17,134) (957) (94) (174)
Interest Expense 1,518 3,263 168 197
Income Before Tax (18,652) (4,220) (262) (371)
Income Tax Expense
Minority Interest 19 (1) (1) (1)
Net Income From Continuing Ops (18,633) (4,221) (263) (372)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (18,636) (4,220) (262) (371)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (18,636) (4,220) (262) (371)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

AgraFlora Organics International Inc. (AGRA) (AGFAF) Receives Purchase Order from Asian CBD Distribution Joint Venture

AgraFlora Organics Receives Purchase Order from Asian CBD Distribution Joint Venture AgraFlora…

Green Thumb Industries Inc. (GTBIF) Expands National Retail Footprint to Over 100 Stores Nationwide

Green Thumb Expands National Retail Footprint to Over 100 Stores Nationwide with…

HEXO Corp (HEXO) Announces Changes to its Board of Directors

HEXO Announces Changes to its Board of Directors HEXO Corp (“HEXO”, or…

$GWPH Initiates Second Phase 3 Pivotal Study of Epidiolex(R)

GW Pharmaceuticals Initiates Second Phase 3 Pivotal Study of Epidiolex(R) (CBD) in…